Exact Mass: 370.093953
Exact Mass Matches: 370.093953
Found 93 metabolites which its exact mass value is equals to given mass value 370.093953,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Fraxin
Fraxin is a beta-D-glucoside that is fraxetin attached to a beta-D-glucopyranosyl group at position 8 via a glycosidic linkage. It is a natural product isolated from the leaves of Fraxinus excelsior and exhibits potent hepatoprotective effects in vitro and in vivo. It has a role as a plant metabolite, an anti-inflammatory agent and a hepatoprotective agent. It is a beta-D-glucoside, a hydroxycoumarin and an aromatic ether. It is functionally related to a fraxetin. Fraxin is a natural product found in Acer nikoense, Prunus prostrata, and other organisms with data available. A beta-D-glucoside that is fraxetin attached to a beta-D-glucopyranosyl group at position 8 via a glycosidic linkage. It is a natural product isolated from the leaves of Fraxinus excelsior and exhibits potent hepatoprotective effects in vitro and in vivo. Origin: Plant, Coumarins Fraxin isolated from Cortex Fraxini, is a glucoside of fraxetin and reported to exert potent anti-oxidative stress action[1], anti-inflammatory and antimetastatic properties. Fraxin shows its antioxidative effect through inhibition of cyclo AMP phosphodiesterase enzyme[2]. Fraxin isolated from Cortex Fraxini, is a glucoside of fraxetin and reported to exert potent anti-oxidative stress action[1], anti-inflammatory and antimetastatic properties. Fraxin shows its antioxidative effect through inhibition of cyclo AMP phosphodiesterase enzyme[2].
5-Hydroxy-6-methoxycoumarin 7-glucoside
5-Hydroxy-6-methoxycoumarin 7-glucoside is found in alcoholic beverages. 5-Hydroxy-6-methoxycoumarin 7-glucoside is isolated from Prunus spinosa (sloe). Isolated from Prunus spinosa (sloe). 5-Hydroxy-6-methoxycoumarin 7-glucoside is found in alcoholic beverages, herbs and spices, and fruits.
Remoxipride
Remoxipride is only found in individuals that have used or taken this drug. It is an antipsychotic agent that is specific for dopamine D2 receptors. It has been shown to be effective in the treatment of schizophrenia. [PubChem]Remoxipride acts as an antagonist at the D2 dopamine receptor. It is believed that overactivity of dopamine systems in the mesolimbic pathway may contribute to the "positive symptoms" of schizophrenia (such as delusions and hallucinations), whereas problems with dopamine function in the mesocortical pathway may be responsible for the "negative symptoms", such as avolition, flat emotional response and alogia. Therefore, by decreasing the levels of dopamine in these pathways, it is thought that remoxipride is able to reduce the symptoms of schizophrenia, particularily the "positive symptoms". D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AL - Benzamides C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist
Ferulic acid 4-O-glucuronide
Ferulic acid 4-O-glucuronide is a polyphenol metabolite detected in biological fluids (PMID: 20428313). Ferulic acid 4-O-glucuronide was found to be elevated in rat urine after whole rye consumption which makes this compound a potential urinary biomarker of whole grain intake (PMID: 26862900).
Feruloyl C1-glucuronide
Feruloyl C1-glucuronide is a polyphenol metabolite detected in biological fluids (PMID: 20428313).
Isoferulic acid 3-O-glucuronide
Isoferulic acid 3-O-glucuronide is a polyphenol metabolite detected in biological fluids (PMID: 20428313).
Isoferuloyl C1-glucuronide
Isoferuloyl C1-glucuronide is a polyphenol metabolite detected in biological fluids (PMID: 20428313).
cis-Ferulic acid 4-glucuronide
[(2R,3R,4R,5S)-3,4-Diacetyloxy-5-(2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl acetate
Parecoxib
C19H18N2O4S (370.0987228000001)
M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AH - Coxibs D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D004791 - Enzyme Inhibitors > D016861 - Cyclooxygenase Inhibitors > D052246 - Cyclooxygenase 2 Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor D000893 - Anti-Inflammatory Agents
n-[[(5-Methyl-3-phenylisoxazol-4-yl)-phenyl]sulfonyl]propanamide
C19H18N2O4S (370.0987228000001)
D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D004791 - Enzyme Inhibitors > D016861 - Cyclooxygenase Inhibitors > D052246 - Cyclooxygenase 2 Inhibitors D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents
Tetomilast
C19H18N2O4S (370.0987228000001)
C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor
6,7-Dihydroxy-5-methoxycoumarin 6-beta-D-glucopyranoside
Parecoxib
C19H18N2O4S (370.0987228000001)
M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AH - Coxibs D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D004791 - Enzyme Inhibitors > D016861 - Cyclooxygenase Inhibitors > D052246 - Cyclooxygenase 2 Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor D000893 - Anti-Inflammatory Agents
(E)-3-[6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,3-benzodioxol-5-yl]prop-2-enoic acid
2,3,6,7,8,9-hexahydroxynaphthalene-2-O-alpha-L-(-)-rhamnopyranoside|arjunaphthanoloside
O1-[2-(3-Acetyl-carbazoyl)-phenyl]-beta-D-glucopyranuronsaeure|O1-[2-(3-acetyl-hydrazinocarbonyl)-phenyl]-beta-D-glucopyranuronic acid
5,8-dihydroxy-7-methoxycoumarin-5-beta-glucopyranoside
Monnieriside A
Monnieriside A is a natural product found in Cnidium monnieri with data available.
2-methyl-5,7-dihydroxychromone 8-C-beta-D-glucopyranoside
Mitoglitazone
C19H18N2O4S (370.0987228000001)
MSDC 0160 (Mitoglitazone) is a mitochondrial target of thiazolidinediones (mTOT)-modulating insulin sensitizer and a modulator of mitochondrial pyruvate carrier (MPC). MSDC 0160 is a thiazolidinedione (TZD) with antidiabetic and neuroprotective activities. MSDC 0160 has the potential for Alzheimer′s disease[1][2].
8-hydroxy-6-methoxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one
7-hydroxy-6-methoxy-8-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one
8-hydroxy-6-methoxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one
7-hydroxy-6-methoxy-8-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one [IIN-based: Match]
8-hydroxy-6-methoxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one_major
CAY10415
C19H18N2O4S (370.0987228000001)
MSDC 0160 (Mitoglitazone) is a mitochondrial target of thiazolidinediones (mTOT)-modulating insulin sensitizer and a modulator of mitochondrial pyruvate carrier (MPC). MSDC 0160 is a thiazolidinedione (TZD) with antidiabetic and neuroprotective activities. MSDC 0160 has the potential for Alzheimer′s disease[1][2].
Remoxipride
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AL - Benzamides C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist
5-Hydroxy-6-methoxycoumarin 7-glucoside
Ferulic acid 4-O-glucuronide
Feruloyl C1-glucuronide
Isoferulic acid 3-O-glucuronide
Isoferuloyl C1-glucuronide
6-chloro-3-indoxyl-n-acetyl-beta-d-galactosaminide
Phosphonium,(2-carboxyethyl)triphenyl-, chloride (1:1)
C21H20ClO2P (370.08893800000004)
carbomethoxymethyl triphenylphosphonium chloride
C21H20ClO2P (370.08893800000004)
1H-Pyrrolo[2,3-b]pyridine, 5-bromo-4-fluoro-1-[tris(1-methylethyl)silyl]-
C16H24BrFN2Si (370.08760559999996)
uridine triacetate
A - Alimentary tract and metabolism > A16 - Other alimentary tract and metabolism products > A16A - Other alimentary tract and metabolism products > A16AX - Various alimentary tract and metabolism products C78275 - Agent Affecting Blood or Body Fluid Uridine triacetate (Tri-O-acetyl uridine) is an orally active proagent of Uridine (HY-B1449). Uridine triacetate is quickly absorbed in the gut, and is rapidly deacetylated in the circulation to yield free uridine. Uridine triacetate is used for the research of 5-fluorouracil (5-FU) and capecitabine toxicity, or early-onset cardiac or central nervous system (CNS)[1][2].
Premarin
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen
Thiourea, N-[4-(4-chlorophenyl)-5-methyl-1H-pyrazol-3-yl]-N-(2-phenylethyl)- (9CI)
N-((4-(3-methyl-5-phenylisoxazol-4-yl)phenyl)sulfonyl)propionamide
C19H18N2O4S (370.0987228000001)
(5E)-2-mercapto-3-phenyl-5-(2,4,5-trimethoxybenzylidene)-3,5-dihydro-4H-imidazol-4-one
C19H18N2O4S (370.0987228000001)
4-{[(4-Cyanophenyl)(4H-1,2,4-triazol-4-YL)amino]methyl}phenyl sulfamate
C16H14N6O3S (370.08480540000005)
4-[2-Amino-5-(4-methylsulfonylphenyl)-3-pyridyl]-2-methoxy-phenol
C19H18N2O4S (370.0987228000001)
4-Amino-furazan-3-carboxylic acid [5-(2,4-dimethyl-5-nitro-phenyl)-furan-2-ylmethylene]-hydrazide
6-[3-[(E)-2-carboxyethenyl]-5-methoxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
Premarin
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen
8-hydroxy-7-methoxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one
8-hydroxy-6-methoxy-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one
(11r)-11-(2-carbamimidamidoethyl)-8-hydroxy-13-oxo-12,15-dioxa-4-azatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁴]hexadeca-1(16),2,4,6,8,10(14)-hexaene-3-carboxylic acid
7-hydroxy-5-methoxy-6-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one
11-(2-carbamimidamidoethyl)-8-hydroxy-13-oxo-12,15-dioxa-4-azatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁴]hexadeca-1(16),2,4,6,8,10(14)-hexaene-3-carboxylic acid
2,5-dihydroxy-3-(1h-indol-2-yl)-6-(1h-indol-3-yl)cyclohexa-2,5-diene-1,4-dione
2,5-dihydroxy-3,6-bis(1h-indol-3-yl)cyclohexa-2,5-diene-1,4-dione
(2s,5'as,6's,10'ar)-1',6'-dihydroxy-10'a-(methylsulfanyl)-6',10'-dihydro-3h,5'ah-spiro[1-benzofuran-2,3'-pyrazino[1,2-a]indol]-4'-one
C19H18N2O4S (370.0987228000001)
11,22-diazapentacyclo[13.7.0.0⁴,¹².0⁵,¹⁰.0¹⁶,²¹]docosa-1,3,5,7,9,12,14,16,18,20-decaene-2,13-dicarboxylic acid
1',6'-dihydroxy-10'a-(methylsulfanyl)-6',10'-dihydro-3h,5'ah-spiro[1-benzofuran-2,3'-pyrazino[1,2-a]indol]-4'-one
C19H18N2O4S (370.0987228000001)
5-hydroxy-6-methoxy-7-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-2-one
(2r,5'as,6's,10'ar)-1',6'-dihydroxy-10'a-(methylsulfanyl)-6',10'-dihydro-3h,5'ah-spiro[1-benzofuran-2,3'-pyrazino[1,2-a]indol]-4'-one
C19H18N2O4S (370.0987228000001)